← All trials
NCT00818389
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2009
- Primary completion
- Oct 1, 2009
- Completion date
- Oct 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 84
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Harvard UniversityLead sponsor
- Harvard UniversityOverall official - principal investigator
- Columbia UniversityOverall official - principal investigator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- University of TorontoCollaborator
- Columbia UniversityCollaborator
- University of KentuckyCollaborator
- ALS AssociationCollaborator
- ALS Society of CanadaCollaborator
- State University of New York, SyracuseCollaborator
- University of TorontoOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.